1. Home
  2. PROF vs MCN Comparison

PROF vs MCN Comparison

Compare PROF & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • MCN
  • Stock Information
  • Founded
  • PROF N/A
  • MCN 2004
  • Country
  • PROF Canada
  • MCN Canada
  • Employees
  • PROF N/A
  • MCN N/A
  • Industry
  • PROF Medical/Dental Instruments
  • MCN
  • Sector
  • PROF Health Care
  • MCN
  • Exchange
  • PROF Nasdaq
  • MCN Nasdaq
  • Market Cap
  • PROF 149.7M
  • MCN 127.3M
  • IPO Year
  • PROF N/A
  • MCN N/A
  • Fundamental
  • Price
  • PROF $5.50
  • MCN $6.27
  • Analyst Decision
  • PROF Strong Buy
  • MCN
  • Analyst Count
  • PROF 1
  • MCN 0
  • Target Price
  • PROF $11.00
  • MCN N/A
  • AVG Volume (30 Days)
  • PROF 28.5K
  • MCN 52.9K
  • Earning Date
  • PROF 08-14-2025
  • MCN 01-01-0001
  • Dividend Yield
  • PROF N/A
  • MCN 9.96%
  • EPS Growth
  • PROF N/A
  • MCN N/A
  • EPS
  • PROF N/A
  • MCN N/A
  • Revenue
  • PROF $11,862,000.00
  • MCN N/A
  • Revenue This Year
  • PROF $63.99
  • MCN N/A
  • Revenue Next Year
  • PROF $117.19
  • MCN N/A
  • P/E Ratio
  • PROF N/A
  • MCN N/A
  • Revenue Growth
  • PROF 75.01
  • MCN N/A
  • 52 Week Low
  • PROF $3.90
  • MCN $6.69
  • 52 Week High
  • PROF $9.87
  • MCN $8.60
  • Technical
  • Relative Strength Index (RSI)
  • PROF 47.57
  • MCN 57.09
  • Support Level
  • PROF $5.49
  • MCN $6.16
  • Resistance Level
  • PROF $5.96
  • MCN $6.26
  • Average True Range (ATR)
  • PROF 0.27
  • MCN 0.06
  • MACD
  • PROF 0.01
  • MCN 0.00
  • Stochastic Oscillator
  • PROF 46.83
  • MCN 89.47

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About MCN Madison Covered Call & Equity Strategy Fund

XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.

Share on Social Networks: